Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Piper Sandler analyst Christopher Raymond initiates coverage on Tyra Biosciences (NASDAQ:TYRA) with a Overweight rating and ...
Wedbush analyst Robert Driscoll reiterates Tyra Biosciences (NASDAQ:TYRA) with a Outperform and maintains $28 price target.
Oppenheimer analyst Matthew Biegler maintains Tyra Biosciences (NASDAQ:TYRA) with a Outperform and lowers the price target f...
Tyra Biosciences (NASDAQ:TYRA) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0....
Oppenheimer analyst Matthew Biegler reiterates Tyra Biosciences (NASDAQ:TYRA) with a Outperform and maintains $28 price target.
Wedbush analyst Robert Driscoll reiterates Tyra Biosciences (NASDAQ:TYRA) with a Outperform and maintains $28 price target.
HC Wainwright & Co. analyst Mitchell Kapoor reiterates Tyra Biosciences (NASDAQ:TYRA) with a Buy and maintains $23 price...
